X Bioscience Public Company Limited
X Bioscience Public Company Limited, together with its subsidiaries, sells food and beverages in Thailand. It engages in the food and beverages investment and restaurant businesses. The company also manufactures and sells biological products; and generates and transmits electric power. Its brands include Kagonoya, Le Boeuf, and Bake Cheese Tart. The company was formerly known as Wow Factor Public… Read more
X Bioscience Public Company Limited (XBIO) - Total Liabilities
Latest total liabilities as of September 2024: ฿544.00 Million THB
Based on the latest financial reports, X Bioscience Public Company Limited (XBIO) has total liabilities worth ฿544.00 Million THB as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
X Bioscience Public Company Limited - Total Liabilities Trend (2020–2023)
This chart illustrates how X Bioscience Public Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
X Bioscience Public Company Limited Competitors by Total Liabilities
The table below lists competitors of X Bioscience Public Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Puget Technologies Inc
PINK:PUGE
|
USA | $128.25K |
|
BIJOU BRIGITTE
MU:BIJ
|
Germany | €167.78 Million |
|
Grupo Famsa S.A.B. de C.V
MX:GFAMSAA
|
Mexico | MX$25.93 Billion |
|
Intergama
TA:INTR
|
Israel | ILA26.66 Million |
|
BERKELEY GRP - Dusseldorf Stock Exchang
DU:42BA
|
Germany | €3.44 Billion |
|
Hiru Corporation
PINK:HIRU
|
USA | $8.40 Million |
Liability Composition Analysis (2020–2023)
This chart breaks down X Bioscience Public Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how X Bioscience Public Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for X Bioscience Public Company Limited (2020–2023)
The table below shows the annual total liabilities of X Bioscience Public Company Limited from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | ฿556.58 Million | -6.86% |
| 2022-12-31 | ฿597.55 Million | -7.67% |
| 2021-12-31 | ฿647.19 Million | +94.68% |
| 2020-12-31 | ฿332.44 Million | -- |